Stay updated on Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.

Latest updates to the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check35 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.3%
- Check78 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference1.0%
- Check85 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added, indicating a future event on February 18, 2025.SummaryDifference1.0%
Stay in the know with updates to Vobramitamab Dose Levels in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vobramitamab Dose Levels in Prostate Cancer Clinical Trial page.